About Alpha-9 Oncology
Through peptide engineering and iterative design, Alpha9 Oncology creates highly selective, potent radiopharmaceuticals for cancer patients.
Leadership at Alpha-9 Oncology
The team at the top of the org chart.
Alison Fleming
COO
24 reports
Stephen Mitchener
Chief Business Officer
1 report
Mark Dornan
Vice President, Pharmaceutical Development & External Manufacturing
12 reports
RM
Robert Meehan
Chief Medical Officer
3 reports
AB
Alexander Butte
Sr. Director, Clinical Operations
2 reports
CN
Chethana Naik
Senior Director Quality Assurance
1 report
Susan Wenckus Surabian
Sr. Administrative Assistant
Megan Bumgarner
Director, Tx Pharmaceutical Development
KL
Katherine Li
Executive Director Business Development